Skip to main content

Q&As

The Who and When of Intralesional Injections for HS Treatment
Q&As
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist
Treating Actinic Keratosis: Insights from a Phase 3 Trial on Tirbanibulin
Q&As
03/09/2021
Ted Lain, MD, MBA, is chief medical officer of Sanova Dermatology, based in Texas and Louisiana. Dr Lain spoke with The Dermatologist about the results of a recent phase 3 trial evaluating tirbanibulin as a...
Ted Lain, MD, MBA, is chief medical officer of Sanova Dermatology, based in Texas and Louisiana. Dr Lain spoke with The Dermatologist about the results of a recent phase 3 trial evaluating tirbanibulin as a...
Ted...
03/09/2021
The Dermatologist
Identifying Pain in Atopic Dermatitis
Q&As
02/23/2021
In this Q&A, Dr Yosipovitch speaks about the relationship of pain and AD, how to consider pain in these patients, and what therapies may be successful in treating AD-related pain.
In this Q&A, Dr Yosipovitch speaks about the relationship of pain and AD, how to consider pain in these patients, and what therapies may be successful in treating AD-related pain.
In this Q&A, Dr Yosipovitch...
02/23/2021
The Dermatologist
Evaluating AD-Related Pain in Clinical Practice
Q&As
02/18/2021
Jonathan Silverberg, MD, spoke with The Dermatologist regarding recent research into pain as a symptom of atopic dermatitis (AD) and how dermatologists can evaluate AD-related pain within clinical practice.
Jonathan Silverberg, MD, spoke with The Dermatologist regarding recent research into pain as a symptom of atopic dermatitis (AD) and how dermatologists can evaluate AD-related pain within clinical practice.
Jonathan Silverberg, MD, spoke...
02/18/2021
The Dermatologist
Updates in Urticaria: What Dermatologists Should Know
Q&As
02/17/2021
Urticaria, with its characteristic pruritic weals and angioedema, can be frustrating for patients and a challenge for dermatologists to treat. No matter whether patients experience an acute or chronic case,...
Urticaria, with its characteristic pruritic weals and angioedema, can be frustrating for patients and a challenge for dermatologists to treat. No matter whether patients experience an acute or chronic case,...
...
02/17/2021
The Dermatologist
Examining the Cross Section of Itch and Pain in AD
Q&As
01/24/2021
Dr Arendt-Nielsen details the similarities and differences in the pathophysiology of itch and pain, highlighting the need for more research to better understand their relationship.
Dr Arendt-Nielsen details the similarities and differences in the pathophysiology of itch and pain, highlighting the need for more research to better understand their relationship.
Dr Arendt-Nielsen details the...
01/24/2021
The Dermatologist
Q&As
12/14/2020
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist
a
Q&As
10/30/2020
Findings from a recent study highlighted key differences between the molecular phenotype of mild atopic dermatitis and moderate to severe atopic dermatitis. Corresponding author Emma Guttman, MD, PhD, discussed the implications of these key...
Findings from a recent study highlighted key differences between the molecular phenotype of mild atopic dermatitis and moderate to severe atopic dermatitis. Corresponding author Emma Guttman, MD, PhD, discussed the implications of these key...
Findings from a recent study...
10/30/2020
The Dermatologist
a
Q&As
10/30/2020
A recent study evaluated providers’ perceptions of a universal action plan for the management of atopic dermatitis. Corresponding author Collette Utley, DNP, FNC-BC, PNP-BC, discussed the action plan and how it could help physicians in an...
A recent study evaluated providers’ perceptions of a universal action plan for the management of atopic dermatitis. Corresponding author Collette Utley, DNP, FNC-BC, PNP-BC, discussed the action plan and how it could help physicians in an...
A recent study evaluated...
10/30/2020
The Dermatologist
aa
Q&As
09/29/2020
Andrew Alexis, MD, discussed the treatment of acne and postinflammatory hyperpigmentation among skin of color patients in an interview with The Dermatologist.
Andrew Alexis, MD, discussed the treatment of acne and postinflammatory hyperpigmentation among skin of color patients in an interview with The Dermatologist.
Andrew Alexis, MD, discussed the...
09/29/2020
The Dermatologist